Recent applications of nuclear medicine in diagnostics (I part);Nuove applicazioni della medicina nucleare in ambito diagnostico (I parte)

Italian Journal of Medicine

Volumn 4, Issue 2, 2010, Pages 84-91

  Treglia, Giorgio ^a   Cason, Ernesto ^b   Fagioli, Giorgio ^b  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b MAGGIORE HOSPITAL   (Italy)

Author keywords

Nuclear medicine; Oncology; PET CT; SPECT CT

Indexed keywords

RADIOPHARMACEUTICAL AGENT;

BONE METASTASIS; CANCER DIAGNOSIS; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; LYMPH NODE METASTASIS; MEDICAL LITERATURE; MOLECULAR IMAGING; NEUROENDOCRINE TUMOR; NUCLEAR MEDICINE; POSITRON EMISSION TOMOGRAPHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THYROID TUMOR; TREATMENT RESPONSE;

EID: 77957865813     PISSN: 18779344     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.itjm.2010.03.001     Document Type: Article

References (33)

1. A.H. Maurer Combined imaging modalities: PET/CT and SPECT/CT Health Phys 95 5 2008 571 576
2. F.U. Chowdhury, and A.F. Scarsbrook The role of hybrid SPECT-CT in oncology: current and emerging clinical applications Clin Radiol 63 3 2008 241 251
3. V. Rufini, M.L. Calcagni, and R.P. Baum Imaging of neuroendocrine tumors Semin Nucl Med 36 3 2006 228 247
4. O. Schillaci Functional-anatomical image fusion in neuroendocrine tumors Cancer Biother Radiopharm 19 1 2004 129 134
5. K. Tharp, O. Israel, J. Hausmann, L. Bettman, W.H. Martin, and M. Daitzchman Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma Eur J Nucl Med Mol Imaging 31 10 2004 1435 1442
6. E. Even-Sapir, H. Lerman, G. Lievshitz, A. Khafif, D.M. Fliss, and A. Schwartz Lymphoscintigraphy for sentinel node mapping using a hybrid SPECT/CT system J Nucl Med 44 9 2003 1413 1420
7. E. Even-Sapir Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities J Nucl Med 46 8 2005 1356 1367
8. W. Römer, A. Nömayr, M. Uder, W. Bautz, and T. Kuwert SPECT-guided CT for evaluating foci of increased bone metabolism classified as indeterminate on SPECT in cancer patients J Nucl Med 47 7 2006 1102 1106
9. D.W. Townsend Positron emission tomography/computed tomography Semin Nucl Med 38 3 2008 152 166
10. O. Mawlawi, and D.W. Townsend Multimodality imaging: an update on PET/CT technology Eur J Nucl Med Mol Imaging 36 Suppl 1 2009 S15 29
11. E. Mittra, and A. Quon Positron emission tomography/computed tomography: the current technology and applications Radiol Clin North Am 47 1 2009 147 160
12. G.K. Von Schulthess, and T.F. Hany Imaging and PET-PET/CT imaging J Radiol 89 3 Pt 2 2008 438 447
13. D. Lardinois, W. Weder, T.F. Hany, E.M. Kamel, S. Korom, and B. Seifert Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography N Engl J Med 348 25 2003 2500 2507 (Pubitemid 36706537)
14. Z. Keidar, N. Haim, and L. Guralnik PET/CT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management J Nucl Med 45 10 2004 1640 1646
15. G. Antoch, J. Stattaus, A.T. Nemat, S. Marnitz, T. Beyer, and H. Kuehl Non-small cell lung cancer: dual-modality PET/CT in preoperative staging Radiology 229 2 2003 526 533
16. I.F. Ciernik, E. Dizendorf, B.G. Baumert, B. Reiner, C. Burger, and J.B. Davis Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study Int J Radiat Oncol Biol Phys 57 3 2003 853 863
17. M.B. Wallace, P.J. Nietert, C. Earle, M.J. Krasna, R.H. Hawes, and B.J. Hoffman An analysis of multiple staging management strategies for carcinoma of the esophagus: computed tomography, endoscopic ultrasound, positron emission tomography, and thoracoscopy/laparoscopy Ann Thorac Surg 74 4 2002 1026 1032
18. B.L. Brücher, W. Weber, M. Bauer, U. Fink, N. Avril, and H.J. Stein Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography Ann Surg 233 3 2001 300 309 (Pubitemid 32187807)
19. F.P. Esteves, D.M. Schuster, and R.K. Halkar Gastrointestinal tract malignancies and positron emission tomography: an overview Semin Nucl Med 36 2 2006 169 181
20. E. Pelosi, and D. Deandreis The role of 18F-fluoro-deoxy-glucose positron emission tomography (FDG-PET) in the management of patients with colorectal cancer Eur J Surg Oncol 33 1 2007 1 6
21. S.M. Swetter, L.A. Carroll, D.L. Johnson, and G.M. Segall Positron emission tomography is superior to computed tomography for metastatic detection in melanoma patients Ann Surg Oncol 9 7 2002 646 653
22. J.D. Wagner, D. Schauwecker, D. Davidson, T. Logan, J.J. Coleman 3rd, and G. Hutchins Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma Cancer 104 3 2005 570 579
23. E. Pelosi, P. Pregno, D. Penna, D. Deandreis, A. Chiappella, and G. Limerutti Role of whole-body [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and conventional techniques in the staging of patients with Hodgkin and aggressive non Hodgkin lymphoma Radiol Med 113 4 2008 578 590
24. J. Altamirano, J.R. Esparza, J. de la Garza Salazar, P.S. Calvo, S.R. Vera, and J.R. Chalapud Revelo Staging, response to therapy, and restaging of lymphomas with 18F-FDG PET Arch Med Res 39 1 2008 69 77
25. Y. Yamazaki, M. Saitoh, K. Notani, K. Tei, Y. Totsuka, and S. Takinami Assessment of cervical lymph node metastases using FDG-PET in patients with head and neck cancer Ann Nucl Med 22 3 2008 177 184
26. A. Tan, D.J. Adelstein, L.A. Rybicki, J.P. Saxton, R.M. Esclamado, and B.G. Wood Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy Arch Otolaryngol Head Neck Surg 133 5 2007 435 440
27. B. Zangheri, C. Messa, M. Picchio, L. Gianolli, C. Landoni, and F. Fazio PET/CT and breast cancer Eur J Nucl Med Mol Imaging 31 Suppl 1 2004 S135 S142
28. A. Shammas, B. Degirmenci, J.M. Mountz, B.M. McCook, B. Branstetter, and B. Bencherif 18F-FDG PET/CT in patients with suspected recurrent or metastatic welldifferentiated thyroid cancer J Nucl Med 48 2 2007 221 226
29. D. Grisaru, B. Almog, C. Levine, U. Metser, A. Fishman, and H. Lerman The diagnostic accuracy of 18F-fluorodeoxyglucose PET/CT in patients with gynaecological malignancies Gynecol Oncol 94 3 2004 680 684
30. H. Petrowsky, P. Wildbrett, D.B. Husarik, T.F. Hany, S. Tam, and W. Jochum Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma J Hepatol 45 1 2006 43 50
31. S. Heinrich, G.W. Goerres, M. Schäfer, M. Sagmeister, P. Bauerfeind, and B.C. Pestalozzi Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness Ann Surg 242 2 2005 235 243
32. G.W. Goerres, R. Stupp, G. Barghouth, T.F. Hany, B. Pestalozzi, and E. Dizendorf The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: long-term outcome of treatment with imatinib mesylate Eur J Nucl Med Mol Imaging 32 2 2005 153 162
33. W. Chen, and D.H. Silverman Advances in evaluation of primary brain tumors Semin Nucl Med 38 4 2008 240 250